Rossari Biotech Ltd

Rossari Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Rossari Biotech Ltd

₹ 699 -0.75%
25 Apr - close price
rossari.com BSE: 543213 NSE: ROSSARI
About

Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]

Their 3 main product categories are [2]:
- Home, personal care, and performance chemicals
- Textile specialty chemical
- Animal health and nutrition

The company has two R&D facilities, one at Silvassa manufacturing facility and a research lab at IIT Bombay. [3]

Key Points

Product Segments
The company is one of India’s leading specialty chemicals manufacturer offering 4,280+ products across 3 verticals: [1]

Website BSE NSE
  • Market Cap ₹ 3,872 Cr.
  • Current Price ₹ 699
  • High / Low ₹ 973 / 568
  • Stock P/E 33.7
  • Book Value ₹ 195
  • Dividend Yield 0.07 %
  • ROCE 15.2 %
  • ROE 11.3 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.59 times its book value
  • Company has a low return on equity of 10.3% over last 3 years.
  • Dividend payout has been low at 3.02% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
262 234 241 237 264 258 332 299 314 301 336 368 427
234 207 213 205 228 223 290 258 272 261 292 318 374
Operating Profit 27 27 28 32 36 35 42 41 42 40 44 50 52
OPM % 10% 12% 12% 13% 14% 14% 13% 14% 13% 13% 13% 14% 12%
2 1 0 0 2 1 2 2 1 1 1 1 2
Interest 1 1 1 2 1 2 3 3 2 2 2 2 3
Depreciation 7 6 6 7 7 6 6 6 7 6 7 7 8
Profit before tax 22 21 21 24 30 29 36 35 35 33 37 41 44
Tax % 22% 26% 26% 26% 23% 26% 26% 27% 25% 26% 26% 26% 26%
17 15 15 17 23 22 26 26 26 24 27 31 32
EPS in Rs 3.06 2.79 2.80 3.17 4.20 3.91 4.78 4.62 4.74 4.40 4.96 5.53 5.84
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
122 178 233 292 516 600 690 1,073 975 1,203 1,432
108 166 209 247 438 495 569 950 853 1,042 1,245
Operating Profit 13 12 24 45 78 105 121 123 123 161 186
OPM % 11% 7% 10% 15% 15% 18% 18% 11% 13% 13% 13%
0 0 1 1 1 4 10 13 4 7 6
Interest 3 3 2 1 3 4 3 3 5 10 10
Depreciation 5 4 4 5 12 17 22 26 26 24 28
Profit before tax 6 5 19 39 63 88 106 107 96 134 155
Tax % 11% 29% 17% 27% 28% 26% 25% 26% 25% 26% 26%
5 3 16 29 46 66 79 79 71 100 115
EPS in Rs 11.59 7.77 35.43 65.73 104.07 12.91 15.23 14.43 12.94 18.04 20.72
Dividend Payout % 1% 0% 1% 0% 0% 4% 3% 3% 4% 3% 2%
Compounded Sales Growth
10 Years: %
5 Years: 19%
3 Years: 10%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 12%
3 Years: 14%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -9%
1 Year: -9%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 10%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 4 4 10 10 11 11 11 11
Reserves 27 41 56 85 116 273 394 774 848 949 1,066
38 22 24 22 9 67 0 0 65 68 50
24 37 37 49 119 118 140 141 202 253 324
Total Liabilities 93 104 122 160 248 468 544 926 1,126 1,281 1,451
43 36 37 44 74 94 171 177 157 167 179
CWIP 0 8 8 10 3 22 0 1 14 25 34
Investments 0 0 0 3 0 15 9 381 493 528 538
50 60 77 103 171 338 364 367 462 561 699
Total Assets 93 104 122 160 248 468 544 926 1,126 1,281 1,451

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 23 2 22 72 56 52 33 113 74
0 -5 -6 -16 -41 -187 -37 -318 -160 -70
0 -18 3 -6 -26 155 -29 297 61 -22
Net Cash Flow 0 1 -0 -1 5 23 -14 12 14 -18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 70 59 74 75 61 57 73 62 91 92 96
Inventory Days 77 70 52 65 59 57 72 48 58 61 62
Days Payable 83 79 70 71 114 95 100 51 92 92 100
Cash Conversion Cycle 63 50 56 69 6 19 44 58 58 61 58
Working Capital Days 78 42 54 66 24 38 61 63 63 77 92
ROCE % 27% 42% 55% 38% 29% 18% 12% 14% 15%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
68.56% 68.46% 68.44% 68.44% 68.44% 68.35% 68.34% 68.32% 68.32% 68.27% 68.19% 68.18%
8.51% 8.84% 8.63% 7.46% 6.12% 5.74% 4.14% 4.02% 3.83% 3.74% 3.74% 3.98%
13.02% 14.15% 14.08% 15.09% 17.71% 17.68% 18.06% 17.74% 16.87% 17.34% 17.47% 17.59%
9.91% 8.55% 8.85% 9.01% 7.73% 8.23% 9.45% 9.90% 10.98% 10.64% 10.60% 10.24%
No. of Shareholders 98,56595,66497,08196,63495,37195,2001,00,42398,8591,00,47597,18895,73592,852

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls